Organizing Committee Members - Internal Medicine 2019
Chief Quality Officer for SKMC
American University of Beirut
Dr. Samer Ellahham(Biography)
Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Healthcare Leader, Dr. Ellahham has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality, patient safety, patient experience and risk management. Dr. Ellahham is a recognized leader in quality, safety, patient experience, risk management and the use of robust performance improvement in improving healthcare delivery. He serves on a number of US and international committees and advisory bodies. He is the Middle East Regional Chair of the Patient Safety Movement Foundation. Dr. Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is one the nominees for Safe Care magazine Person of the Year in the United States. Dr. Ellahham is the recipient of prestigious SKMC Infection Prevention Award in 2011 and 2012. He is recognized worldwide for Excellence in infection prevention and control. Dr. Ellahham is Middle East Representative of the JCI Standards Subcommittee and Member on the Editorial Advisory Board of the Joint Commission Journal on Quality and Patient Safety. He is reviewer of HCAC Cardiac Quality and Safety Standards. Dr. Ellahham has been a champion of the use of Lean, Six Sigma and Change Management to improve healthcare quality. He is Lean Six Sigma Master Black Belted. He was the Leader of the First Pilot International Robust Process Improvement (RPI) project by the Joint Commission Center for Transforming Healthcare and several other similar successful performance improvement projects at SKMC. He is Lead Trainer in TeamSTEPPS Lead Trainer. Dr. Ellahham is certified as EFQM 2013 Model assessor and is leading EFQM Excellence Model at SKMC with great success including winning the prestigious Sheikh Khalifa Excellence Award in 2014, Dubai Quality Award in 2015 and Sheikh Khalifa Excellence Golden Award in 2015. Dr. Ellahham is the Executive SKMC sponsor of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIPÂ®) the leading US validated, risk-adjusted, outcomes-based program to measure and improve the quality of surgical care. SKMC is the first multispecialty ACS NSQIP center outside the US. Dr. Ellahham led the publication of, first in the region, annual SKMC outcome books since 2011. He is a strong believer in transparency in health care and external reporting. Dr. Ellahham is a Board-certified internist, cardiologist and vascular medicine senior consultant and continues to care for patients. He received his undergraduate degree in biology and his M.D. from the American University of Beirut. He did his fellowship in Cardiology at the Medical College of Virginia (MCV) in USA. After completing his fellowship, Dr. Ellahham worked in Washington DC in several clinical and leadership positions before moving to UAE in 1988. He led the First AHA GWTG Heart Failure Initiative outside US and was the recipient of the AHA GWTG Award in Wash. DC. His clinical passion and expertise is in the field of heart failure management. He demonstrated great skill and experience in the management of patients with heart failure and led a multi-disciplinary team in the care and delivery of advanced therapies to these patients. He has unique abilities to partner and engage local and regional referring providers. He is able to work in a highly matrixed environment, possess strong leadership and organizational skills and have experience to working effectively in a large health system. He is currently Cleveland Clinic Staff and on the Executive Team of The Cleveland Clinic Foundation, in Abu Dhabi, UAE. Dr. Ellahham is a fellow of the American College of Cardiology, American College of Chest Physicians, American College of Physicians, and American Heart Association. He is the Eminent Editor of The Journal of Cardiology & Cardiovascular Therapy. In addition, he serves is on the editorial board of the Joint Commission Journal on Quality and Patient Safety, Open Access Journal of Clinical Trials, Hypertension Today Journal and Focus on Hypertension Journal. Dr. Ellahham is a Distinguished Fellow of the New Westminster College in British Columbia, Canada. Dr. Ellahham is an avid researcher; his research includes lean six sigma, change management, innovation, safety, outcomes research, risk management, safe surgery, heart failure, diabetes mellitus, genetics, cardiac imaging, sports and nutrition. He is a recognized world-leader in these fields. He received several research awards including the DuPont Pharmaceuticals Research Award, ACCP 58th Annual Scientific Assembly, Young Investigator Award; the Alfred Soffer Research Award, ACCP 58th Annual Scientific Assembly, Finalist; the First Young Investigator Award 12th, Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery, and the American Heart Association Get with the Guidelines Award. Dr. Ellahham is on the editorial board of Medical Science, Open Journal of Cardiatic Research and was on the editorial board of The Joint Commission Journal on Quality and Patient Safety. He is also a reviewer for several peer-reviewed journals, including Joint Commission Journal on Quality and Patient Safety, International Journal of Quality & Reliability Management, the Journal of American College of Cardiology, the American Heart Journal, Annals of Internal Medicine, Archives of Internal Medicine, Chest, Circulation, Clinical Cardiology, Chest, Lancet ,Diabetes Care, Archives of Internal Medicine, Endocrinology and Metabolism, European Journal of Heart Failure, Congestive Heart Failure Journal, Journal of Nuclear Cardiology, the Journal of Transplant Coordination, the Journal of Cardiovascular Pharmacology and the Southern Medical Journal, European Journal of Innovation Management and The Anatolian Journal of cardiology.
Dr. Samer Ellahham(Research Area)
I.M.Sechenov First Moscow State Medical University
Dr Sergey Suchkov, MD, PhD. Professor in Medicine. Director, Center for Personalized Medicine, I.M.Sechenov First Moscow State Medical University, and Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born 11.01.1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, Nat Inst of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Inst of Med Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Inst in Moscow; Trainee: NEI, NIH, Bethesda, MD, USA; Chair, Dept for Clin Immunology, Moscow Clin Research Inst (MONIKI); Exe Secretary-in-Chief of the Editorial Board, Biomedical Science International; Director, the Center of Personalized Medicine, I.M.Sechenov First Moscow State Medical Univ, and Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Honours: Secretary General, United Cultural Convention (UCC), Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels, EU.
Sergey Suchkov(Research Area)
Personalized, Precision and Translational Medicine, Immunology and Immunogenetics
Ioannina University School of Medicine
Professor. D. Roukos(Biography)
Dimitrios H. Roukos, MD, PhD, is the founding director of Centre for Biosystems and Genome Network Medicine in the Ioannina University, School of Medicine. Assessing the current and future unmet needs of traditional clinical research and single-gene linear transcription-based targeted therapy, he has moved to clinical cancer genome sequencing, regulatory molecular networks and nonlinear transcription. Comprehensive intrapatient landscapes of genomic alterations represent his current research focus. With over 232 papers, including 80 on next-generation sequencing and 32 on precision medicine-oncology, 8,130 citations, h-index of 70, reviewer for high impact journals, editorial board member in more then 25 high-impact journal, lecturer and organizing committee member for international conferences, he is an internationally recognized leading expert of precision cancer genome medicine.
Professor. D. Roukos(Research Area)
precision cancer genome medicine
MD, Specialist in internal medicine
PZU Sistina nefroplus, Macedonia
Republic of Macedonia
Biography (Max. 250 words) Katerina Ristoska, MD is a graduate of Medical Faculty, Skopje, Republic of Macedonia, where she also attended her specialization in internal medicine. Dr.Ristoska trained at Medical Faculty, Skopje, at the Department of Nephrology during her residency. During her residency, she was able to provide superior care and consulatation that resulted in an overall improvement of the department's patient satisfaction quotien. She complited training in dialysology and focused on the patient treatment and reevaluated several methods of therapy management dependent on individual patent history and efficacy of previous treatment. Dr.Ristoska has been practicing and attended her undergraduate studies in the Department of Cardiology at Medical Faculty in Skopje. She is currently author and coauthor of 57 publication at the international congresses at home and abroad, as same in the several other journals.She was contributor on two multicentric studies of pharmaceutical company"Krka-Farma" DOOEL Skopje.Dr.Ristoska is Fellow of New Westminster College, Vancouver, British Columbia, Canada. She is the Member of The Macedonian Association of internal medicine, ESC, EAPCI, HFA, EACVI, EAPC, ACCA. She is also the Member of ESC Council on Cardiovascular Nursing and Allied Professions, ESC Council on Hypertension, ESC Council on Valvular Heart Disease, the Member of Working Group on Grown-up Congenital Heart Disease, the Member of Working Group on Aorta & Peripheral vascular disease. Dr.Ristoska is the Member of ERA â€“ EDTA Diabesity Group, ERA â€“ EDTA EUREKA -M Working Group of European renal and Cardiovascular medicine, ERA - EDTA CKD- MBD Working Group. She is also an accredited examiner of a doctor's professional exam for obtaining a work license. After her extensive work experience in a children's dispensary, emergency unit, surgery unit, private health sector, she is currently working in the hemodialysis center of Sistina nephroplus. Ristoska acts as a volunteer in many humanitarian organizations dealing with women's health, child health, animal protection. Currently, Dr.Ristoska holds certification from the Macedonian Board of Internal Medicine. Research Interest
Katerina Ristoska(Research Area)